Dr Bradley D Connett, MD | |
1075 Nichols Rd, Osage Beach, MO 65065-3093 | |
(573) 302-3111 | |
(573) 302-2869 |
Full Name | Dr Bradley D Connett |
---|---|
Gender | Male |
Speciality | Urology |
Location | 1075 Nichols Rd, Osage Beach, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750356663 | NPI | - | NPPES |
340017670 | Other | RAILROAD MEDICARE | |
100153430B | Medicaid | KS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 102732 (Missouri) | Primary |
208800000X | Urology | 0424419 (Kansas) | Secondary |
208800000X | Urology | 26727 (Kentucky) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Bradley D Connett, MD 1075 Nichols Rd, Osage Beach, MO 65065-3093 Ph: (573) 302-3111 | Dr Bradley D Connett, MD 1075 Nichols Rd, Osage Beach, MO 65065-3093 Ph: (573) 302-3111 |
News Archive
AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced experimental results highlighting that its prototype bacteriophage cocktail demonstrated comparable efficacy to vancomycin in reduction of Staphylococcus aureus in a murine lung infection model.
Chronic opioid prescribing in primary care varies significantly by patient and clinician characteristics, according to a new study.
Treating people with mental ill health in hospitals with locked wards, as opposed to hospitals without locked wards, does not reduce their risk of suicide attempts or of unauthorised absence from hospital, also known as ‘absconding', according to a new 15-year study in Germany of around 145000 patient cases, published in The Lancet Psychiatry journal.
University of Washington researchers have helped develop a new kind of microscope to visualize cells in three dimensions, an advance that could bring great progress in the field of early cancer detection.
KYTHERA Biopharmaceuticals, Inc. and Intendis, Bayer HealthCare's dermatology business, today announced the initiation of two European Phase III studies evaluating ATX-101, a first-in-class injectable adipolytic agent, for the reduction of localized fat under the chin (submental fat).
› Verified 2 days ago
Eric W Mcqueary, D.O. Urology Medicare: May Accept Medicare Assignments Practice Location: 1029 Nichols Rd Ste 401, Osage Beach, MO 65065 Phone: 573-302-3111 Fax: 573-302-2869 |